CompletedNCT00234689
Naltrexone added to an SSRI for OCD
About this title
Read the official source — NCT00234689This study evaluated the effectiveness of Naltrexone for people with OCD.
Medication studyAges 18–65Israel
Understand this study
What did researchers investigate?
This study evaluated the effectiveness of Naltrexone for people with OCD.
Who was this study for?
This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Ramat GanSee all locations and recruitment
Study information
Study start dateJanuary 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Sheba Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Israel
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00234689
- Official title
Show the full official title
Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ramat Gan
Questions about this study
What did researchers investigate?
This study evaluated the effectiveness of Naltrexone for people with OCD.
Who is behind this study?
The study sponsor is Sheba Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Naltrexone.
Who was this study for?
This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
